This prospective study was conducted in October 2018 to October 2022. The study was approved by the faculty ethics committee [IRB approval code 5786-11-12-2019] and all patients signed an informed consent for the details of the procedure. Sample size was calculated assuming that mean ± SD for incontinence impact in autologous group versus synthetic group was 43.3 ± 47.3 VS 73.3 ± 38.8, the sample size was calculated to be 60 (30 in each group ) with confidence interval 95% & power of the test 85% using open EPI. Outcome measures: cure was defined as no leakage based on both symptom scale scoring and physical examination. improvement was defined as ≥ 50% decrease in symptoms based on the questionnaire‘s results.
We included all the patients with pure stress urinary incontinence scheduled for TOT as defined by the symptom of involuntary urine leakage on any increase of intra-abdominal pressure (e.g. coughing, exertion, etc.) and confirmed objectively by clinical evaluation. We excluded patients with detrusor overactivity and/or detrusor overactivity UI as confirmed by urodynamics. Patients who had significant pelvic organ prolapse that required surgical correction or had a history of previous prolapse repair, or active UTI, or having evidence of voiding dysfunction and patients with a PVR > 100 mL by urodynamics, were excluded from enrolment into the study.
Patients evaluation included standardized history, clinical examination (including stress test), numbers of pads/24 h,, and objectively confirmed by complete urodynamic evaluation with Valsalva leak-point pressure (VLPP) recording according to the standards recommended by the ICS [7]. Both uroflowmetry results and post-void residual urine volume (PVR) were retrieved for comparison and assessment of postoperative voiding dysfunction and urethral obstruction. We used the validated Arabic translation of the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI-SF) questionnaire to assess QoL before surgery, and at the 1 and 6-month postoperative visits [8]. The post operative scores were compared to baseline scores.
The women with SUI were randomized into two groups after inclusion using closed envelope: Group I included women who underwent TOT using hybrid tape and Group II who had a TOT using synthetic sling [DynaMesh®-SIS direct].In group I patients we start to harvest autologous graft from rectus fascia through small pfannenstiel incision the graft is 6 cm length and 2 cm width. We cut the synthetic tape in the center, and then suture the autologous part between the halves of the synthetic tape, and TOT (outside–in) was performed in both groups as described by Delorme et al. [9].
The procedure was timed from the first incision to the last suture, At the end the procedure vaginal pack was left for 12–24 h postoperatively, whilst an indwelling urethral Foley’s catheter (16F) was fixed for 1 day. Intraoperative and immediate postoperative complications, hospital stay, and return to normal activity were calculated.
Follow up Data from at 1 and 6-month postoperative visits were compared with the perioperative variables and QoL.
Descriptive statistical data, perioperative variables were recorded as mean ± SD, whilst postoperative surgical outcome in percentage for comparison between the groups .Statistical analysis was performed using paired t-test and z test, with a P ≤ 0.05considered to indicate statistical significance.